Response to Afatinib in a Common EGFR-Mutated Lung Adenocarcinoma with a Very Rare Combination of Compound Mutations
Turk Thorac J
.
2022 Sep;23(5):364-365.
doi: 10.5152/TurkThoracJ.2022.22034.
Authors
Hiroaki Satoh
1
,
Kunihiko Miyazaki
2
,
Yoshiharu Sato
3
,
Nobuyuki Hizawa
4
Affiliations
1
Division of Respiratory Medicine, Mito Medical Center, University of Tsukuba.
2
Division of Respiratory Medicine, Ryugasaki Saiseikai Hospital.
3
DNA Chip Research Inc. (Tokyo, Japan).
4
Division of Respiratory Medicine, Faculty of Clinical Medicine, University of Tsukuba.
PMID:
35957568
PMCID:
PMC9524493
DOI:
10.5152/TurkThoracJ.2022.22034
No abstract available